Copley’s comprehensive range of world leading products for inhaler testing extends to equipment, software and services for every stage of development for both innovator and generic products.
The devices used for inhaled and nasal drug delivery are collectively referred to as orally inhaled and nasal drug products (OINDPs). Contact us for more information of the products.
The DDU is the total mass of drug emitted from the inhaler and hence available to the patient.Delivered Dose Uniformity (DDU) is measured by firing the test device into a sampling apparatus which contains a filter. The active drug caught on the filter is then dissolved in solvent and analysed using High Pressure Liquid Chromatography (HPLC).
The Aerodynamic Particle Size Distribution (ASPD), along with Delivered dose, is widely recognised as a Critical Quality Attribute in the in vitro characterisation of OINDPs. The ASPD of an aerosol will determine where the particles in that cloud are going to deposit in the body, amongst other information.
Delivered Dose Uniformity (DDU)
Designed for MDIs, BAIs, DPIs, Nebulisers, ADIs & other Nasal Products
Next Generation Impactor (NGI)
A new impactor of ACI specifically designed for testing MDIs, DPIs and ADIs
Spray Force Tester Model SFT 1000
Measuring the maximum impaction force of MDIs & nasal sprays over the duration of the spray plume
Plume Temperature Tester Model PTT 1000
Consists of a polypropylene sampling tube, w the horizontal section of the USP Induction Port.
Generate an inhalation and/or exhalation profile that mimics that of a human subject
Critical Flow & Breath Actuation Control
Control the test conditions needed when analysing DPIs, MDIs, Nebulisers, ADIs & other Nasal Products
Flow Meters with the required range & accuracy to measure the flow in inhaler testing systems